コンパニオンアニマル用薬剤の市場規模、シェア、動向分析レポート：製品別、動物別、適応症別、流通チャネル別、地域別、セグメント予測、2025年～2034年

コンパニオンアニマル用薬剤市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、コンパニオンアニマル用薬剤の世界市場規模は2034年までに669億6,000万米ドルに達し、2025年から2034年にかけて11.14%のCAGRで拡大すると予測されています。

コンパニオンアニマル用薬剤市場の成長を促進する主な要因は、ペット数の増加、疾病の有病率の増加、ペット保険の利用可能性などです。

例えばカナダでは、カナダ動物衛生研究所（CAHI）によると、2022年には同国の世帯の半数以上（約60％）が少なくとも1匹の犬または猫を飼っています。犬の飼育頭数は2020年の770万頭から2022年には790万頭に増加し、猫の飼育頭数は2020年の810万頭から2022年には850万頭に増加します。CAHIはまた、2020年のCOVID-19の流行開始後、ネコの獣医の受診が急増したと報告しています。

COVID-19の大流行はコンパニオンアニマル用薬剤市場に顕著な影響を与えました。その影響とは、売上の減少、サプライチェーンの課題、経営上の困難、入院患者の減少、需要の減少などです。例えば、エランコ社は2020年第2四半期に20％の減収を報告しました。特にコンパニオンアニマル部門は、国際市場におけるブランド力の低下や、ワクチンなどクリニックで投与される医薬品の減少が悪影響を及ぼしました。

同社は2020年下半期に売上高の回復を報告しています。一方、Vetoquinol社は、動物病院や診療所へのアクセスが制限されているにもかかわらず、動物用医薬品を含む必要不可欠なポートフォリオにより、2020年には売上高が増加すると報告しました。ベーリンガーインゲルハイムもコンパニオンアニマル・セグメントで売上増を記録しました。

世界中でペットの数が増加する中、ペットの人間化の動向はいくつかの主要市場で牽引役となっています。ペットの保護者は、ペットの健康、治療、幸福に対する意識が高まっています。そのため、ペットの経済的リスクを軽減するためにペット保険の導入が増加しています。英国最大のペット保険会社であるペットプランは、犬、猫、馬、小型哺乳類、鳥類、爬虫類、ウサギ、多頭飼いなど、さまざまな種類のペットに保険を提供しています。これらの保険は、健康診断やオンライン診察、処方薬、診断テスト、手術、歯の怪我、ガン治療などを補償します。

ペットの疾病蔓延率の上昇も市場成長に寄与すると予想される主要因です。例えば、内部寄生虫や外部寄生虫による寄生虫感染症は、一般的にペットに影響を与えます。膿皮症の場合、抗生物質や局所療法が処方されることが多いです。しかし、慢性または再発性の膿皮症の場合は、さらなる検査と薬用シャンプーによる定期的な入浴が処方されることもあります。例えば、Vivaldis社のViv Silkyシャンプーは、表在性および深在性膿皮症を含む様々な真菌および細菌感染症に適応があります。

コンパニオンアニマル用薬剤市場レポートハイライト

• 医薬品セグメントは2024年に59.53%の最大市場シェアを占めました。コンパニオンアニマル用薬剤セグメントには、複数の健康状態を治療するための様々な製品が含まれます。
• コンパニオンアニマル用薬剤業界における犬セグメントは、ペットの飼育の普及、獣医学的ヘルスケア支出の増加、犬疾患用に設計された医薬品の利用可能性の増加により、力強い成長を遂げています。
• 感染症分野は、伝染性疾患の負担の増大と予防医療への関心の高まりに牽引され、2024年のコンパニオンアニマル用薬剤の世界市場を独占しました。
• 2024年の流通チャネル別では、病院薬局セグメントが市場を独占しました。大きなシェアを占める要因としては、病院での患者数の増加、ペットが診断されたらすぐに必要な薬を購入できる利便性などが挙げられます。
• 北米地域は2024年に市場を独占し、36.04%以上の最大の収益シェアを記録しました。これは、この地域の一人当たりの動物ヘルスケア支出が高く、ペットの飼い主が多いためです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 北米のコンパニオンアニマル用薬剤市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 補助市場の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 市場機会分析
  • 市場課題分析
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
• 製品別価格分析
• 規制の枠組み
• 製品パイプライン分析
• COVID-19の影響分析
• 主要種による推定疾患蔓延率分析

第4章 世界のコンパニオンアニマル用薬剤市場：製品別推定・動向分析

• セグメントダッシュボード
• 世界のコンパニオンアニマル用薬剤市場：製品別変動分析、2024年および2034年
  • 生物学的製剤
  • 医薬品
  • 薬用飼料添加物

第5章 世界のコンパニオンアニマル用薬剤市場：動物別推定・動向分析

• セグメントダッシュボード
• 世界のコンパニオンアニマル用薬剤市場：動物別変動分析、2024年および2034年
  • 犬
  • 猫
  • 馬
  • その他の動物

第6章 世界のコンパニオンアニマル用薬剤市場：適応症別推定・動向分析

• セグメントダッシュボード
• 世界のコンパニオンアニマル用薬剤市場：適応症別変動分析、2024年および2034年
  • 感染症
  • 皮膚疾患
  • 痛み
  • 整形外科疾患
  • 行動障害
  • その他の適応症

第7章 世界のコンパニオンアニマル用薬剤市場：流通チャネル別推定・動向分析

• セグメントダッシュボード
• 世界のコンパニオンアニマル用薬剤市場：流通チャネル別変動分析、2024年および2034年
  • 小売り
  • eコマース
  • 病院/クリニック薬局

第8章 世界のコンパニオンアニマル用薬剤市場：地域別推定・動向分析

• 地域別市場シェア分析、2024年および2034年
• 地域市場ダッシュボード
• 地域市場のスナップショット
• 市場規模、予測動向分析、2018年から2034年まで：
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 参入企業の分類
• 企業の市況分析/ヒートマップ分析
• 企業プロファイル
  • Merck &Co., Inc.
  • Ceva
  • Vetoquinol
  • Zoetis
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Incorporated
  • Ourofino Animal Health
  • Virbac
  • Phibro Animal Health Corporation
  • Dechra Pharmaceuticals Plc
  • Bimeda Inc.
• 戦略マッピング
  • 合併と買収
  • パートナーシップとコラボレーション
  • 拡大
  • 製品発売
  • その他
• その他の主要プレーヤーのリスト

List of Tables

• Table 1. List of Secondary Sources
• Table 2. List of Abbreviations
• Table 3. Global Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
• Table 4. Global Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
• Table 5. Global Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
• Table 6. Global Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
• Table 7. Global Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
• Table 8. Global Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
• Table 9. Global Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
• Table 10. Global Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
• Table 11. Global Companion Animal Medicine Market, by Region, 2018 - 2034 (USD Million)
• Table 12. North America Companion Animal Medicine Market, by Country, 2018 - 2034 (USD Million)
• Table 13. North America Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
• Table 14. North America Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
• Table 15. North America Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
• Table 16. North America Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
• Table 17. North America Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
• Table 18. North America Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
• Table 19. North America Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
• Table 20. North America Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
• Table 21. U.S. Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
• Table 22. U.S. Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
• Table 23. U.S. Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
• Table 24. U.S. Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
• Table 25. Canada Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
• Table 26. Canada Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
• Table 27. Canada Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
• Table 28. Canada Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
• Table 29. Canada Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
• Table 30. Canada Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
• Table 31. Canada Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
• Table 32. Canada Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
• Table 33. Mexico Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
• Table 34. Mexico Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
• Table 35. Mexico Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
• Table 36. Mexico Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
• Table 37. Mexico Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
• Table 38. Mexico Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
• Table 39. Mexico Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
• Table 40. Mexico Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
• Table 41. Europe Companion Animal Medicine Market, by Country, 2018 - 2034 (USD Million)
• Table 42. Europe Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
• Table 43. Europe Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
• Table 44. Europe Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
• Table 45. Europe Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
• Table 46. Europe Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
• Table 47. Europe Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
• Table 48. Europe Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
• Table 49. Europe Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
• Table 50. Germany Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
• Table 51. Germany Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
• Table 52. Germany Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
• Table 53. Germany Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
• Table 54. Germany Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
• Table 55. Germany Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
• Table 56. Germany Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
• Table 57. Germany Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
• Table 58. UK Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
• Table 59. UK Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
• Table 60. UK Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
• Table 61. UK Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
• Table 62. UK Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
• Table 63. UK Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
• Table 64. UK Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
• Table 65. UK Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
• Table 66. France Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
• Table 67. France Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
• Table 68. France Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
• Table 69. France Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
• Table 70. France Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
• Table 71. France Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
• Table 72. France Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
• Table 73. France Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
• Table 74. Italy Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
• Table 75. Italy Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
• Table 76. Italy Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
• Table 77. Italy Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
• Table 78. Italy Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
• Table 79. Italy Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
• Table 80. Italy Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
• Table 81. Italy Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
• Table 82. Spain Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
• Table 83. Spain Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
• Table 84. Spain Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
• Table 85. Spain Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
• Table 86. Spain Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
• Table 87. Spain Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
• Table 88. Spain Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
• Table 89. Spain Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
• Table 90. Denmark Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
• Table 91. Denmark Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
• Table 92. Denmark Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
• Table 93. Denmark Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
• Table 94. Denmark Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
• Table 95. Denmark Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
• Table 96. Denmark Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
• Table 97. Denmark Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
• Table 98. Sweden Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
• Table 99. Sweden Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
• Table 100. Sweden Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
• Table 101. Sweden Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
• Table 102. Sweden Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
• Table 103. Sweden Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
• Table 104. Sweden Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
• Table 105. Sweden Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
• Table 106. Norway Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
• Table 107. Norway Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
• Table 108. Norway Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
• Table 109. Norway Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
• Table 110. Norway Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
• Table 111. Norway Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
• Table 112. Norway Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
• Table 113. Norway Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
• Table 114. Asia Pacific Companion Animal Medicine Market, by Country, 2018 - 2034 (USD Million)
• Table 115. Asia Pacific Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
• Table 116. Asia Pacific Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
• Table 117. Asia Pacific Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
• Table 118. Asia Pacific Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
• Table 119. Asia Pacific Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
• Table 120. Asia Pacific Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
• Table 121. Asia Pacific Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
• Table 122. Asia Pacific Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
• Table 123. China Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
• Table 124. China Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
• Table 125. China Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
• Table 126. China Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
• Table 127. China Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
• Table 128. China Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
• Table 129. China Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
• Table 130. China Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
• Table 131. Japan Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
• Table 132. Japan Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
• Table 133. Japan Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
• Table 134. Japan Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
• Table 135. Japan Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
• Table 136. Japan Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
• Table 137. Japan Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
• Table 138. Japan Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
• Table 139. India Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
• Table 140. India Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
• Table 141. India Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
• Table 142. India Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
• Table 143. India Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
• Table 144. India Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
• Table 145. India Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
• Table 146. India Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
• Table 147. South Korea Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
• Table 148. South Korea Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
• Table 149. South Korea Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
• Table 150. South Korea Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
• Table 151. South Korea Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
• Table 152. South Korea Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
• Table 153. South Korea Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
• Table 154. South Korea Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
• Table 155. Australia Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
• Table 156. Australia Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
• Table 157. Australia Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
• Table 158. Australia Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
• Table 159. Australia Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
• Table 160. Australia Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
• Table 161. Australia Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
• Table 162. Australia Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
• Table 163. Thailand Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
• Table 164. Thailand Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
• Table 165. Thailand Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
• Table 166. Thailand Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
• Table 167. Thailand Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
• Table 168. Thailand Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
• Table 169. Thailand Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
• Table 170. Thailand Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
• Table 171. Latin America Companion Animal Medicine Market, by Country, 2018 - 2034 (USD Million)
• Table 172. Latin America Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
• Table 173. Latin America Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
• Table 174. Latin America Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
• Table 175. Latin America Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
• Table 176. Latin America Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
• Table 177. Latin America Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
• Table 178. Latin America Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
• Table 179. Latin America Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
• Table 180. Brazil Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
• Table 181. Brazil Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
• Table 182. Brazil Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
• Table 183. Brazil Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
• Table 184. Brazil Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
• Table 185. Brazil Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
• Table 186. Brazil Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
• Table 187. Brazil Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
• Table 188. Argentina Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
• Table 189. Argentina Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
• Table 190. Argentina Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
• Table 191. Argentina Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
• Table 192. Argentina Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
• Table 193. Argentina Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
• Table 194. Argentina Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
• Table 195. Argentina Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
• Table 196. Middle East & Africa Companion Animal Medicine Market, by Country, 2018 - 2034 (USD Million)
• Table 197. Middle East & Africa Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
• Table 198. Middle East & Africa Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
• Table 199. Middle East & Africa Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
• Table 200. Middle East & Africa Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
• Table 201. Middle East & Africa Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
• Table 202. Middle East & Africa Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
• Table 203. Middle East & Africa Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
• Table 204. Middle East & Africa Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
• Table 205. South Africa Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
• Table 206. South Africa Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
• Table 207. South Africa Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
• Table 208. South Africa Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
• Table 209. South Africa Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
• Table 210. South Africa Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
• Table 211. South Africa Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
• Table 212. South Africa Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
• Table 213. Saudi Arabia Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
• Table 214. Saudi ArabiaCompanion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
• Table 215. Saudi ArabiaCompanion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
• Table 216. Saudi ArabiaCompanion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
• Table 217. Saudi ArabiaCompanion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
• Table 218. Saudi Arabia Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
• Table 219. Saudi Arabia Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
• Table 220. Saudi Arabia Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
• Table 221. UAE Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
• Table 222. UAE Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
• Table 223. UAE Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
• Table 224. UAE Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
• Table 225. UAE Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
• Table 226. UAE Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
• Table 227. UAE Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
• Table 228. UAE Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
• Table 229. Kuwait Companion Animal Medicine Market, By Product, 2018 - 2034 (USD Million)
• Table 230. Kuwait Companion Animal Medicine Market, Vaccines, 2018 - 2034 (USD Million)
• Table 231. Kuwait Companion Animal Medicine Market, Other Biologics, 2018 - 2034 (USD Million)
• Table 232. Kuwait Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
• Table 233. Kuwait Companion Animal Medicine Market, Pharmaceuticals, 2018 - 2034 (USD Million)
• Table 234. Kuwait Companion Animal Medicine Market, By Animal, 2018 - 2034 (USD Million)
• Table 235. Kuwait Companion Animal Medicine Market, By Indication, 2018 - 2034 (USD Million)
• Table 236. Kuwait Companion Animal Medicine Market, By Distribution Channel, 2018 - 2034 (USD Million)
• Table 237. Company Overview
• Table 238. Product Benchmarking
• Table 239. Financial Performance
• Table 240. Strategic Initiatives

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information Procurement
• Fig. 3 Primary Research Pattern
• Fig. 4 Market Research Approaches
• Fig. 5 Value Chain-Based Sizing & Forecasting
• Fig. 6 Market Formulation & Validation
• Fig. 7 Companion Animal Medicine Market, Market Segmentation
• Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
• Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 12 Porter's Five Forces Analysis
• Fig. 13 Regional Marketplace: Key Takeaways
• Fig. 14 Global Companion Animal Medicine Market, for Product, 2018 - 2034 (USD Million)
• Fig. 15 Global Companion Animal Medicine Market, for Biologics, 2018 - 2034 (USD Million)
• Fig. 16 Global Companion Animal Medicine Market, for Vaccines, 2018 - 2034 (USD Million)
• Fig. 17 Global Companion Animal Medicine Market, for Modified/ Attenuated Live, 2018 - 2034 (USD Million)
• Fig. 18 Global Companion Animal Medicine Market, for Inactivated (Killed), 2018 - 2034 (USD Million)
• Fig. 19 Global Companion Animal Medicine Market, for Other Vaccines, 2018 - 2034 (USD Million)
• Fig. 20 Global Companion Animal Medicine Market, for Other Biologics, 2018 - 2034 (USD Million)
• Fig. 21 Global Companion Animal Medicine Market, for Monoclonal Antibody (mAb), 2018 - 2034 (USD Million)
• Fig. 22 Global Companion Animal Medicine Market, for Dogs, 2018 - 2034 (USD Million)
• Fig. 23 Global Companion Animal Medicine Market, for Cats, 2018 - 2034 (USD Million)
• Fig. 24 Global Companion Animal Medicine Market, for Other Biologics (excluding mAb), 2018 - 2034 (USD Million)
• Fig. 25 Global Companion Animal Medicine Market, for Pharmaceuticals, 2018 - 2034 (USD Million)
• Fig. 26 Global Companion Animal Medicine Market, for Parasiticides, 2018 - 2034 (USD Million)
• Fig. 27 Global Companion Animal Medicine Market, for Anti-infectives, 2018 - 2034 (USD Million)
• Fig. 28 Global Companion Animal Medicine Market, for Anti-inflammatory, 2018 - 2034 (USD Million)
• Fig. 29 Global Companion Animal Medicine Market, for Analgesics, 2018 - 2034 (USD Million)
• Fig. 30 Global Companion Animal Medicine Market, for Other Pharmaceuticals, 2018 - 2034 (USD Million)
• Fig. 31 Global Companion Animal Medicine Market, for Medicated Feed Additives, 2018 - 2034 (USD Million)
• Fig. 32 Global Companion Animal Medicine Market, for Animal, 2018 - 2034 (USD Million)
• Fig. 33 Global Companion Animal Medicine Market, for Dogs, 2018 - 2034 (USD Million)
• Fig. 34 Global Companion Animal Medicine Market, for Cats 2018 - 2034 (USD Million)
• Fig. 35 Global Companion Animal Medicine Market, for Horses 2018 - 2034 (USD Million)
• Fig. 36 Global Companion Animal Medicine Market, for Other Animals 2018 - 2034 (USD Million)
• Fig. 37 Global Companion Animal Medicine Market, for Indication 2018 - 2034 (USD Million)
• Fig. 38 Global Companion Animal Medicine Market, for Infectious Diseases 2018 - 2034 (USD Million)
• Fig. 39 Global Companion Animal Medicine Market, for Dermatologic Diseases 2018 - 2034 (USD Million)
• Fig. 40 Global Companion Animal Medicine Market, for Pain 2018 - 2034 (USD Million)
• Fig. 41 Global Companion Animal Medicine Market, for Orthopedic Diseases 2018 - 2034 (USD Million)
• Fig. 42 Global Companion Animal Medicine Market, for Behavioral Diseases 2018 - 2034 (USD Million)
• Fig. 43 Global Companion Animal Medicine Market, for Other Indications 2018 - 2034 (USD Million)
• Fig. 44 Global Companion Animal Medicine Market, for Distribution Channel 2018 - 2034 (USD Million)
• Fig. 45 Global Companion Animal Medicine Market, for Retail 2018 - 2034 (USD Million)
• Fig. 46 Global Companion Animal Medicine Market, for E-commerce 2018 - 2034 (USD Million)
• Fig. 47 Global Companion Animal Medicine Market, for Hospitals/Clinics 2018 - 2034 (USD Million)
• Fig. 48 Regional Outlook, 2024 & 2034
• Fig. 49 North America Companion Animal Medicine Market, 2018 - 2034 (USD Million)
• Fig. 50 U.S. Companion Animal Medicine Market, 2018 - 2034 (USD Million)
• Fig. 51 Canada Companion Animal Medicine Market, 2018 - 2034 (USD Million)
• Fig. 52 Mexico Companion Animal Medicine Market, 2018 - 2034 (USD Million)
• Fig. 53 Europe Companion Animal Medicine Market, 2018 - 2034 (USD Million)
• Fig. 54 Germany Companion Animal Medicine Market, 2018 - 2034 (USD Million)
• Fig. 55 UK Companion Animal Medicine Market, 2018 - 2034 (USD Million)
• Fig. 56 France Companion Animal Medicine Market, 2018 - 2034 (USD Million)
• Fig. 57 Italy Companion Animal Medicine Market, 2018 - 2034 (USD Million)
• Fig. 58 Spain Companion Animal Medicine Market, 2018 - 2034 (USD Million)
• Fig. 59 Denmark Companion Animal Medicine Market, 2018 - 2034 (USD Million)
• Fig. 60 Sweden Companion Animal Medicine Market, 2018 - 2034 (USD Million)
• Fig. 61 Norway Companion Animal Medicine Market, 2018 - 2034 (USD Million)
• Fig. 62 Asia Pacific Companion Animal Medicine Market, 2018 - 2034 (USD Million)
• Fig. 63 Japan Companion Animal Medicine Market, 2018 - 2034 (USD Million)
• Fig. 64 China Companion Animal Medicine Market, 2018 - 2034 (USD Million)
• Fig. 65 India Companion Animal Medicine Market, 2018 - 2034 (USD Million)
• Fig. 66 Australia Companion Animal Medicine Market, 2018 - 2034 (USD Million)
• Fig. 67 South Korea Companion Animal Medicine Market, 2018 - 2034 (USD Million)
• Fig. 68 Thailand Companion Animal Medicine Market, 2018 - 2034 (USD Million)
• Fig. 69 Latin America Companion Animal Medicine Market, 2018 - 2034 (USD Million)
• Fig. 70 Brazil Companion Animal Medicine Market, 2018 - 2034 (USD Million)
• Fig. 71 Argentina Companion Animal Medicine Market, 2018 - 2034 (USD Million)
• Fig. 72 Middle East and Africa Companion Animal Medicine Market, 2018 - 2034 (USD Million)
• Fig. 73 South Africa Companion Animal Medicine Market, 2018 - 2034 (USD Million)
• Fig. 74 Saudi Arabia Companion Animal Medicine Market, 2018 - 2034 (USD Million)
• Fig. 75 UAE Companion Animal Medicine Market, 2018 - 2034 (USD Million)
• Fig. 76 Kuwait Companion Animal Medicine Market, 2018 - 2034 (USD Million)
• Fig. 77 Heat map analysis

Companion Animal Medicine Market Growth & Trends:

The global companion animal medicine market size is expected to reach USD 66.96 billion by 2034 and is expected to expand at 11.14% CAGR from 2025 to 2034, according to a new report by Grand View Research, Inc. The key factors driving the growth of the market for companion animal medicine include the rising pet population, the increased prevalence of diseases, and the availability of pet insurance.

In Canada for example, more than half of the country's households (around 60% of households) owned at least one dog or cat in 2022, according to the Canadian Animal Health Institute (CAHI). The country's dog population increased from 7.7 million in 2020 to 7.9 million in 2022, whereas the cat population increased from 8.1 million in 2020 to 8.5 million in 2022. CAHI also reported a surge in feline vet visits following the start of the COVID-19 outbreak in 2020.

The COVID-19 pandemic notably affected the market for companion animal medicine. The impact included dampened sales, supply chain challenges, operational hurdles, falling inpatient visits, and reduced demand. Elanco for instance reported a 20% decline in revenue during Q2 2020. The company's companion animal segment, in particular, was adversely impacted by the fall in brands in international markets and those administered in the clinic e.g. vaccines.

The company reported a recovery in sales during H2 2020. Vetoquinol on the other hand reported an increase in sales, driven by its essential portfolio including veterinary drugs in 2020 despite limited access to vet clinics and hospitals due to lockdown protocols. Boehringer Ingelheim too registered increased sales in the companion animal segment.

With the rising number of pets across the globe, the trend of pet humanization has gained traction in several key markets. Pet guardians are becoming increasingly aware of their pet's health, treatment, and well-being. This has increased the adoption of pet insurance to reduce the financial risks for them. Petplan- the largest pet insurance provider in the U.K. offers insurance policies for various species including dogs, cats, horses, small mammals, birds, reptiles, rabbits, and multi-pet owners. These policies provide coverage for physical and online consultations, prescription medicine, diagnostic tests, surgery, dental injury, cancer treatment, and more.

The rising prevalence of diseases in pets is another key driver expected to contribute to market growth. Parasitic infections from internal and external parasites for example, commonly affect pets. Antibiotics and topical therapies are often prescribed in the case of pyoderma. However, further testing and routine bathing with medicated shampoos may be prescribed in case of chronic or recurring pyoderma. For example, Viv Silky Shampoo by Vivaldis is indicated for various fungal and bacterial infections including superficial and deep pyoderma.

Companion Animal Medicine Market Report Highlights:

• The pharmaceuticals segment held the largest market share of 59.53% in 2024. The pharmaceuticals segment for companion animals includes various products to treat multiple health conditions.
• The dog segment within the companion animal medicine industry is experiencing robust growth, driven by widespread pet ownership, increasing veterinary healthcare spending, and the growing availability of medicines designed for canine conditions.
• The infectious diseases segment dominated the global companion animal medicine in 2024, driven by the growing burden of transmissible diseases and heightened focus on preventive care.
• The hospital pharmacy segment dominated the market by distribution channel in 2024. The factors contributing to the large share include higher patient footfalls at hospitals and the convenience of buying the necessary medications as soon as the pet is diagnosed
• North America region dominated the market in 2024 and registered the largest revenue share of over 36.04%. This is due to the region's high per capita animal healthcare spending and a large number of pet owners

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definition
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information/Data Analysis
• 1.6. Market Formulation & Visualization
• 1.7. Data Validation & Publishing
• 1.8. Model Details
  • 1.8.1. Commodity flow analysis
  • 1.8.2. Global Market: CAGR Calculation
• 1.9. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. North America Companion Animal Medicine Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rapid Advancements in the Field of Companion Animal Medicine
    • 3.2.1.2. Increasing Humanization of Pets & Expenditure on Pets
    • 3.2.1.3. Support Initiatives
    • 3.2.1.4. Changing Pet Demographics Globally
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Emergence of Adverse Drug Reactions (ADR)
    • 3.2.2.2. Complex Regulations
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
  • 3.2.5. Industry Analysis - Porter's
    • 3.2.5.1. Bargaining power of the suppliers
    • 3.2.5.2. Bargaining power of the buyers
    • 3.2.5.3. Threats of substitution
    • 3.2.5.4. Threats from new entrants
    • 3.2.5.5. Competitive rivalry
  • 3.2.6. PESTEL Analysis
    • 3.2.6.1. Political landscape
    • 3.2.6.2. Economic and Social landscape
    • 3.2.6.3. Technological landscape
• 3.3. Pricing Analysis, by Product
• 3.4. Regulatory framework
• 3.5. Product Pipeline Analysis
• 3.6. COVID-19 Impact Analysis
• 3.7. Estimated Disease Prevalence Analysis by Key Species

Chapter 4. Global Companion Animal Medicine Market: By Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Companion Animal Medicine Market: By Product Movement Analysis, 2024 & 2034 (USD Million)
  • 4.2.1. Biologics
    • 4.2.1.1. Biologics Market Estimates And Forecasts, 2018 - 2034 (USD Million)
    • 4.2.1.2. Vaccines
      • 4.2.1.2.1. Vaccines Market Estimates And Forecasts, 2018 - 2034 (USD Million)
      • 4.2.1.2.2. Modified/ Attenuated Live
        • 4.2.1.2.2.1. Modified/ Attenuated Live Market Estimates And Forecasts, 2018 - 2034 (USD Million)
      • 4.2.1.2.3. Inactivated (Killed)
        • 4.2.1.2.3.1. Inactivated (Killed) Market Estimates And Forecasts, 2018 - 2034 (USD Million)
      • 4.2.1.2.4. Other Vaccines
        • 4.2.1.2.4.1. Other Vaccines Market Estimates And Forecasts, 2018 - 2034 (USD Million)
    • 4.2.1.3. Other Biologics
      • 4.2.1.3.1. Other Biologics Market Estimates And Forecasts, 2018 - 2034 (USD Million)
      • 4.2.1.3.2. Monoclonal Antibody (mAb)
        • 4.2.1.3.2.1. Monoclonal Antibody (mAb) Market Estimates And Forecasts, 2018 - 2034 (USD Million)
        • 4.2.1.3.2.2. Dogs
          • 4.2.1.3.2.2.1. Dogs Market Estimates And Forecasts, 2018 - 2034 (USD Million)
        • 4.2.1.3.2.3. Cats
          • 4.2.1.3.2.3.1. Cats Market Estimates And Forecasts, 2018 - 2034 (USD Million)
      • 4.2.1.3.3. Other Biologics (excluding mAb)
        • 4.2.1.3.3.1. Other Biologics (excluding mAb) Market Estimates And Forecasts, 2018 - 2034 (USD Million)
  • 4.2.2. Pharmaceuticals
    • 4.2.2.1. Pharmaceuticals Market Estimates And Forecasts, 2018 - 2034 (USD Million)
    • 4.2.2.2. Parasiticides
      • 4.2.2.2.1. Parasiticides Market Estimates And Forecasts, 2018 - 2034 (USD Million)
    • 4.2.2.3. Anti-infectives
      • 4.2.2.3.1. Anti-infectives Market Estimates And Forecasts, 2018 - 2034 (USD Million)
    • 4.2.2.4. Anti-inflammatory
      • 4.2.2.4.1. Anti-inflammatory Market Estimates And Forecasts, 2018 - 2034 (USD Million)
    • 4.2.2.5. Other Pharmaceuticals
      • 4.2.2.5.1. Other Pharmaceuticals Market Estimates And Forecasts, 2018 - 2034 (USD Million)
  • 4.2.3. Medicated Feed Additives
    • 4.2.3.1. Medicated Feed Additives Market Estimates And Forecasts, 2018 - 2034 (USD Million)

Chapter 5. Global Companion Animal Medicine Market: By Animal Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Companion Animal Medicine Market: By Animal Movement Analysis, 2024 & 2034 (USD Million)
  • 5.2.1. Dogs
    • 5.2.1.1. Dogs Market Estimates And Forecasts, 2018 - 2034 (USD Million)
  • 5.2.2. Cats
    • 5.2.2.1. Cats Market Estimates And Forecasts, 2018 - 2034 (USD Million)
  • 5.2.3. Horses
    • 5.2.3.1. Horses Market Estimates And Forecasts, 2018 - 2034 (USD Million)
  • 5.2.4. Other Animals
    • 5.2.4.1. Other Animals Market Estimates And Forecasts, 2018 - 2034 (USD Million)

Chapter 6. Global Companion Animal Medicine Market: By Indication Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Companion Animal Medicine Market: By Indication Movement Analysis, 2024 & 2034 (USD Million)
  • 6.2.1. Infectious Diseases
    • 6.2.1.1. Infectious Diseases Market Estimates And Forecasts, 2018 - 2034 (USD Million)
  • 6.2.2. Dermatologic Diseases
    • 6.2.2.1. Dermatologic Diseases Market Estimates And Forecasts, 2018 - 2034 (USD Million)
  • 6.2.3. Pain
    • 6.2.3.1. Pain Market Estimates And Forecasts, 2018 - 2034 (USD Million)
  • 6.2.4. Orthopedic Diseases
    • 6.2.4.1. Orthopedic Diseases Market Estimates And Forecasts, 2018 - 2034 (USD Million)
  • 6.2.5. Behavioral Diseases
    • 6.2.5.1. Behavioral Diseases Market Estimates And Forecasts, 2018 - 2034 (USD Million)
  • 6.2.6. Other Indications
    • 6.2.6.1. Other Indications Market Estimates And Forecasts, 2018 - 2034 (USD Million)

Chapter 7. Global Companion Animal Medicine Market: By Distribution Channel Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Companion Animal Medicine Market: By Distribution Channel Movement Analysis, 2024 & 2034 (USD Million)
  • 7.2.1. Retail
    • 7.2.1.1. Retail Market Estimates And Forecasts, 2018 - 2034 (USD Million)
  • 7.2.2. E-commerce
    • 7.2.2.1. E-commerce Market Estimates And Forecasts, 2018 - 2034 (USD Million)
  • 7.2.3. Hospital/ Clinic Pharmacy
    • 7.2.3.1. Hospital/ Clinic Pharmacy Market Estimates And Forecasts, 2018 - 2034 (USD Million)

Chapter 8. Global Companion Animal Medicine Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2024 & 2034
• 8.2. Regional Market Dashboard
• 8.3. Regional Market Snapshot
• 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2034:
• 8.5. North America
  • 8.5.1. North America market estimates and forecasts 2018 to 2034 (USD Million)
  • 8.5.2. U.S.
    • 8.5.2.1. U.S. market estimates and forecasts 2018 to 2034 (USD Million)
  • 8.5.3. Canada
    • 8.5.3.1. Canada market estimates and forecasts 2018 to 2034 (USD Million)
  • 8.5.4. Mexico
    • 8.5.4.1. Mexico market estimates and forecasts 2018 to 2034 (USD Million)
• 8.6. Europe
  • 8.6.1. Europe market estimates and forecasts 2018 to 2034 (USD Million)
  • 8.6.2. UK
    • 8.6.2.1. UK market estimates and forecasts 2018 to 2034 (USD Million)
  • 8.6.3. Germany
    • 8.6.3.1. Germany market estimates and forecasts 2018 to 2034 (USD Million)
  • 8.6.4. France
    • 8.6.4.1. France market estimates and forecasts 2018 to 2034 (USD Million)
  • 8.6.5. Italy
    • 8.6.5.1. Italy market estimates and forecasts 2018 to 2034 (USD Million)
  • 8.6.6. Spain
    • 8.6.6.1. Spain market estimates and forecasts 2018 to 2034 (USD Million)
  • 8.6.7. Norway
    • 8.6.7.1. Norway market estimates and forecasts 2018 to 2034 (USD Million)
  • 8.6.8. Sweden
    • 8.6.8.1. Sweden market estimates and forecasts 2018 to 2034 (USD Million)
  • 8.6.9. Denmark
    • 8.6.9.1. Denmark market estimates and forecasts 2018 to 2034 (USD Million)
• 8.7. Asia Pacific
  • 8.7.1. Asia Pacific market estimates and forecasts 2018 to 2034 (USD Million)
  • 8.7.2. Japan
    • 8.7.2.1. Japan market estimates and forecasts 2018 to 2034 (USD Million)
  • 8.7.3. China
    • 8.7.3.1. China market estimates and forecasts 2018 to 2034 (USD Million)
  • 8.7.4. India
    • 8.7.4.1. India market estimates and forecasts 2018 to 2034 (USD Million)
  • 8.7.5. Australia
    • 8.7.5.1. Australia market estimates and forecasts 2018 to 2034 (USD Million)
  • 8.7.6. South Korea
    • 8.7.6.1. South Korea market estimates and forecasts 2018 to 2034 (USD Million)
  • 8.7.7. Thailand
    • 8.7.7.1. Thailand market estimates and forecasts 2018 to 2034 (USD Million)
• 8.8. Latin America
  • 8.8.1. Latin America market estimates and forecasts 2018 to 2034 (USD Million)
  • 8.8.2. Brazil
    • 8.8.2.1. Brazil market estimates and forecasts 2018 to 2034 (USD Million)
  • 8.8.3. Argentina
    • 8.8.3.1. Argentina market estimates and forecasts 2018 to 2034 (USD Million)
• 8.9. MEA
  • 8.9.1. MEA market estimates and forecasts 2018 to 2034 (USD Million)
  • 8.9.2. South Africa
    • 8.9.2.1. South Africa market estimates and forecasts 2018 to 2034 (USD Million)
  • 8.9.3. Saudi Arabia
    • 8.9.3.1. Saudi Arabia market estimates and forecasts 2018 to 2034 (USD Million)
  • 8.9.4. UAE
    • 8.9.4.1. UAE market estimates and forecasts 2018 to 2034 (USD Million)
  • 8.9.5. Kuwait
    • 8.9.5.1. Kuwait market estimates and forecasts 2018 to 2034 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company Participant Categorization
• 9.2. Company Market Position Analysis/ Heat Map Analysis
• 9.3. Company Profile
  • 9.3.1. Merck & Co., Inc.
    • 9.3.1.1. Company overview
    • 9.3.1.2. Financial performance
    • 9.3.1.3. Product benchmarking
    • 9.3.1.4. Strategic initiatives
  • 9.3.2. Ceva
    • 9.3.2.1. Company overview
    • 9.3.2.2. Financial performance
    • 9.3.2.3. Product benchmarking
    • 9.3.2.4. Strategic initiatives
  • 9.3.3. Vetoquinol
    • 9.3.3.1. Company overview
    • 9.3.3.2. Financial performance
    • 9.3.3.3. Product benchmarking
    • 9.3.3.4. Strategic initiatives
  • 9.3.4. Zoetis
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Product benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. Boehringer Ingelheim International GmbH
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Product benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. Elanco Animal Health Incorporated
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Product benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. Ourofino Animal Health
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Product benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. Virbac
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Product benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. Phibro Animal Health Corporation
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Product benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. Dechra Pharmaceuticals Plc
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Product benchmarking
    • 9.3.10.4. Strategic initiatives
  • 9.3.11. Bimeda Inc.
    • 9.3.11.1. Company overview
    • 9.3.11.2. Financial performance
    • 9.3.11.3. Product benchmarking
    • 9.3.11.4. Strategic initiatives
• 9.4. Strategy Mapping
  • 9.4.1. Mergers & Acquisitions
  • 9.4.2. Partnerships & Collaborations
  • 9.4.3. Expansion
  • 9.4.4. Product launch
  • 9.4.5. Others
• 9.5. List of other Key players